Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16546990)

  • 1. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
    Rice PL; Peters SL; Beard KS; Ahnen DJ
    Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
    Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites.
    Rice PL; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2004 Nov; 64(22):8148-51. PubMed ID: 15548677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
    Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
    Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
    Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
    Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
    Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
    Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells.
    Deguchi A; Thompson WJ; Weinstein IB
    Cancer Res; 2004 Jun; 64(11):3966-73. PubMed ID: 15173009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
    Hu Y; Bally M; Dragowska WH; Mayer L
    Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
    Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
    Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
    Moon Y; Yang H; Kim YB
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.
    Thompson WJ; Piazza GA; Li H; Liu L; Fetter J; Zhu B; Sperl G; Ahnen D; Pamukcu R
    Cancer Res; 2000 Jul; 60(13):3338-42. PubMed ID: 10910034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
    Sun Y; Sinicrope FA
    Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
    Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.